38
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Prevention and Treatment of Hepatic Venocclusive Disease after High-Dose Cytoreductive Therapy

&
Pages 267-277 | Received 30 Dec 1997, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alessandro Fulgenzi & Maria Elena Ferrero. (2016) Defibrotide in the treatment of hepatic veno-occlusive disease. Hepatic Medicine: Evidence and Research 8, pages 105-113.
Read now

Articles from other publishers (18)

Miriam Kim, Seema Rao, Jens C. Eickhoff, Kenneth B. DeSantes & Christian M. Capitini. (2020) A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation. Journal of Pediatric Hematology/Oncology 42:2, pages 145-148.
Crossref
May T. Aziz, Payal P. Kakadiya, Samantha M. Kush, Kylie Weigel & Denise K. Lowe. (2017) Defibrotide: An Oligonucleotide for Sinusoidal Obstruction Syndrome. Annals of Pharmacotherapy 52:2, pages 166-174.
Crossref
Joanna L. Gendreau, Christine Knoll, Roberta H. Adams & Leon L. Su. (2017) The Role of Thromboelastography in Pediatric Patients with Sinusoidal Obstructive Syndrome Receiving Defibrotide. Biology of Blood and Marrow Transplantation 23:4, pages 707-712.
Crossref
R R Pol, N Russell, E Das-Gupta, L Watson, L Rachael & J Byrne. (2016) Incidence and management of hepatic severe veno-occlusive disease in 273 patients in a single centre with defibrotide. Bone Marrow Transplantation 51:9, pages 1262-1264.
Crossref
Claudia Seifert, Susan Wittig, Clemens Arndt & Bernd Gruhn. (2014) Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation. Journal of Cancer Research and Clinical Oncology 141:5, pages 877-885.
Crossref
Yona Nadir & Benjamin Brenner. (2012) Thrombotic complications associated with stem cell transplantation. Blood Reviews 26:5, pages 183-187.
Crossref
Constantine S. Mitsiades, Cecile Rouleau, Cinara Echart, Krishna Menon, Beverly Teicher, Maria Distaso, Antonio Palumbo, Mario Boccadoro, Kenneth C. Anderson, Massimo Iacobelli & Paul G. Richardson. (2009) Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias. Clinical Cancer Research 15:4, pages 1210-1221.
Crossref
A Cacchione, A LeMaitre, D Valteau Couanet, E Benhamou, L Amoroso, N Simonnard & O Hartmann. (2008) Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen. Bone Marrow Transplantation 42:7, pages 449-454.
Crossref
V T Ho, C Revta & P G Richardson. (2007) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplantation 41:3, pages 229-237.
Crossref
G.T. Sucak, Z.S. Aki, M. Yag̃cí, Z.A. Yeg̃in, Z.N. Ozkurt & R. Haznedar. (2007) Treatment of Sinusoidal Obstruction Syndrome With Defibrotide: A Single-Center Experience. Transplantation Proceedings 39:5, pages 1558-1563.
Crossref
Yona Nadir & Benjamin Brenner. (2007) Hemorrhagic and thrombotic complications in bone marrow transplant recipients. Thrombosis Research 120, pages S92-S98.
Crossref
Girish Subbarao, Paul R. Haut, Cynthia S. Johnson, Darla Gowan & Jean P. Molleston. (2006) Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation. Pediatric Transplantation 10:6, pages 682-689.
Crossref
Ayman O. Soubani. (2006) Critical care considerations of hematopoietic stem cell transplantation. Critical Care Medicine 34:Suppl, pages S251-S267.
Crossref
Layton H. SmithJohn D. DixonJohn R. StringhamMesut ErenHassan ElokdahDave L. CrandallKay WashingtonDouglas E. Vaughan. (2006) Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis. Blood 107:1, pages 132-134.
Crossref
S Corbacioglu, J Greil, C Peters, N Wulffraat, H J Laws, D Dilloo, B Strahm, U Gross-Wieltsch, K W Sykora, A Ridolfi-Lüthy, O Basu, B Gruhn, T Güngör, W Mihatsch & A S Schulz. (2003) Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplantation 33:2, pages 189-195.
Crossref
C C Barker, J D Butzner, R A Anderson, R Brant & R S Sauve. (2003) Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplantation 32:1, pages 79-87.
Crossref
Lance H. Leopold, Mark S. Berger & Jay Feingoldr. (2002) Acute and Long-Term Toxicities Associated with Gemtuzumab Ozogamicin (Mylotarg®) Therapy of Acute Myeloid Leukemia. Clinical Lymphoma 2, pages S29-S34.
Crossref
Patricia Ribaud & Eliane Gluckman. (1999) Hepatic veno-occlusive disease. Pediatric Transplantation 3, pages 41-44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.